Dr Teiji Akagi is Head, Professor of Adult Congenital Heart Disease Center, Okayama University Hospital, Okayama, Japan. He is the Vice President of Japanese Society of Adult Congenital Heart Disease.

He graduated Kurume University, Kurume, Japan in 1984. He had research fellowship in division of cardiology, The Hospital for Sick Children, Toronto, Canada from 1989 to 92. Since 2004, he works in Cardiac Intensive Care Center, Okayama University Hospital, Okayama, Japan.

His major is catheter intervention of congenital heart disease, adult congenital heart disease. He also has many important works about Kawasaki disease, pulmonary hypertension, cardiac imaging and hemodynamics.

Senior Consultant Paediatric Cardiology
Paediatric & Congenital Heart Centre (PCHC)
Institut Jantung Negara (National Heart Institute), Malaysia

Qualifications:
- MBBS, University of Queensland, Australia, December 1983
- MRCP (UK), September 1988

Speciality:
Paediatric cardiology
Interventional paediatric cardiology

Procedure:
- Simple and complex cardiac congenital diagnostic and interventional procedure
- Hybrid procedure

John Cheatham, MD, is Professor Emeritus, Department of Pediatrics, Cardiology at The Ohio State University College of Medicine and past Co-Director of The Heart Center and Director of Cardiac Catheterization at Nationwide Children's Hospital. After graduating from the University of Oklahoma College of Medicine, he completed his residency at Boston Children's Hospital, followed by a fellowship in Pediatric Cardiology at Texas Children's Hospital in Houston.

Prof Cheatham's area of expertise is transcatheter intervention and Hybrid therapy of newborns, children, and adults with complex congenital heart disease. He has pioneered several new techniques and devices in nonsurgical intervention, as well as being a world leader in developing new Hybrid therapies. Prof Cheatham has been a principal investigator in numerous FDA sponsored clinical trials evaluating nonsurgical transcatheter heart valves, closure devices, and stent therapy over the past two decades. Additionally, Prof Cheatham designed the world's first Hybrid Cardiac Catheterization Suites and advanced imaging equipment at Nationwide Children's Hospital, which allows the interventionalist & cardiothoracic surgeon to perform combined therapy in order to improve clinical outcomes in patients referred to The Heart Center.

Nai-Hsin, Chi, MD, PhD is currently Clinical Associate Professor, Department of Surgery, College of Medicine of National Taiwan University and Attending Physician, Division of Cardiovascular surgery, Department of Surgery, National Taiwan University Hospital

His research fields include: Adult cardiac surgery, Heart transplantation, Mechanical support Aorta surgery, Minimally invasive cardiac surgery

Dr Iksung Cho is Professor (Assistant), Department of Internal Medicine, Yonsei University Hospital, Seoul, Korea

Disciplines: Coronary Artery Disease, Atherosclerosis, Echocardiography

Research Interest: Cardiac Imaging, Valvular Heart Disease, Coronary Atherosclerosis, Cardio-oncology

Specialties: Computed Tomography, Cardio-Oncology, Chronic Heart Failure, Risk Factors and Prevention

Prof. Choi, M.D., Ph.D., FSCAI, is Chief of the Division of Pediatric Cardiology and Director of the Center for Congenital Heart Disease. He also works at Severance Cardiovascular Hospital, Yonsei University College of Medicine

Dr Dalvi, M.D. (Int.Med.), D.M.(Cardiology) is currently a Consultant Pediatric Cardiologist at Glenmark Cardiac Centre, Nanavati Hospital and Breach Candy Hospital at Mumbai. Under his credit, there are numerous national and international publications and he is actively invited as a guest speaker in scientific meetings, CME's and worldwide conferences to talk about pediatric heart surgeries.

His expertise lies in Echocardiographic imaging, Non-surgical cardiac interventions, Balloon pulmonary and aortic valvuloplasties, Dilatation, Stenting of coarctation of the aorta, Angiography, Prevention of Blockage, Atherosclerosis and Heart failure.

Dr Marvin H Eng, FACC, FSCAI, MD( Interventional Cardiology),is currently Structural Fellowship Director of Henry Ford Hospital.

His Specialties include: Percutaneous Coronary Intervention, Peripheral Vascular Interventions, Transcatheter Aortic Valve Replacement, Structural Heart Disease, Valvular Heart Disease, and Transradial Catheterization

Dr. Xavier Freixa is an Interventional Cardiologist at the Hospital Clinic of Barcelona, University of Barcelona. Dr. Freixa has been trained in interventional cardiology at the Toronto General Hospital, University Health Network and the Montreal Heart Institute, University of Montreal.

Dr. Freixa has a major interest in complex percutaneous coronary interventions, structural heart and adult congenital diseases. Among the main areas of interest highlight some advanced percutaneous techniques like PVL repair, left atrial appendage occlusion, ASD/VSD occlusion, TAVI and mitral valve repair with the Mitra-Clip system.

MD, PhD.
Deputy Superintendent,
Taichung Veterans General Hospital

Dr Daisuke Hachinohe is Interventional Cardiologist at the Division of Cardiology and Catheterization Laboratories and Chief of Cardiology Department and Director of Structure Disease Center, Sapporo Cardio Vascular Centre.

His specialities are Interventional Cardiology, Infectious Diseases and Internal Medicine. He was fellow of the heart center of Chonnam National University Hospital, Gwangju, Korea and Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. He is also Member of the Japan Society of Internal Medicine,Japanese Association for Acute Medicine, The Japanese Association for Infectious Diseases, The Japanese Circulation Society, Japanese Association of Cardiovascular Intervention and Therapeutics, The Japan Primary Care Association, The Japan Regenerative Medicine.

Prof. Hara, MD, PhD, is the Associate Professor at the Division of Cardiovascular Medicine, Toho University Ohashi Medical Center. He is specialized in doing PCI, EVT, and SHD intervention such as ASD/PFO/PVL closure, PTMC and BAV etc. Proctor for Occlutech PLD device, one of operators for Watchman Japan trial. He is also the President of Structure Club Japan.

MD, PhD, FESC, FACC, FJCS

Dr Kantaro Hayashida is Assistant Professor Director, Transcatheter Heart Valve program Director, Cardiac Catheterization Laboratory Department of Cardiology, Keio University School of Medicine.

Specialities:
Interventional Cardiology, Imaging, Valvular Heart Disease

Skills and Expertise:
Arteries, Echocardiology, Cardiovascular, Angloplasty, Stents

Prof. Ziyad Hijazi MD, MPH, FACC, MSCAI, FAHA, FPICS
Professor of Pediatrics & Medicine
Weill Cornell Medicine
Chief Medical Officer
Director Sidra Heart Center
Medical Director International Affairs Office
Honorary Professor University of Jordan

Prof. Hijazi is an interventional cardiologist who specializes in treating congenital & structural heart disease in both children and adults. He is a pioneer in the non-surgical repair of congenital and structural heart defects. His major area of interest is in the development of techniques and catheters/devices to help treat or cure congenital and structural cardiac disease without open-heart surgery.

Dr. Reda Ibrahim, MD, CSPQ, FRCPC, has been Interventional Cardiologist at Montreal Heart Institute (Montreal, Canada) since 2002, Medical Director, Structural Heart Program since 2014 and Associate Professor at University of Montreal since 2010

His accomplishment of many novelties include: First-in-Man (FIM): Amplatzer Membranous Ventricular Septal Occluder II, Amplatzer Cardiac Plug (ACP) for left atrial appendage occlusion (LAAO), Proctor in structural interventions (transcatheter aortic valve replacement (TAVR), left atrial appendage occlusion (LAAO), complex congenital procedures)

Within his practice, Dr Hasan Jilaihawi implements innovative technologies in order to offer the least invasive and most effective therapies, without the need for open-heart surgery. These technologies include coronary stenting by the wrist artery, also known as the radial approach, and beating-heart valve replacement and repair, known as transcatheter valve therapy, which can be conducted through the femoral artery or a vein in the leg. These treatments do not require a large incision in the chest.

He is a pioneer of transcatheter valve therapies of the aortic valve. In 2007, he performed the United Kingdom's first transcatheter aortic valve replacement (TAVR) procedure. He has since performed more than 1,000 TAVR procedures worldwide and, through his ongoing support of international colleagues, has helped plan several-fold more.

For the past 10 years, one of his research areas has been the use of advanced imaging to optimize cardiac procedures, including TAVR. Resultant findings have dramatically improved the safety of such procedures, with the worldwide implementation of his TAVR surgical planning methodologies corresponding to a substantial increase in survival rates.

Dr Do-Yoon Kang is an Assistant Professor of Interventional Cardiology at Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea. He received his medical degree from Seoul National University, Seoul, Korea, where he completed internship and residency in internal medicine. He completed his fellowship in interventional cardiology at Asan Medical Center. Dr. Kang's area of clinical expertise is transcatheter valve intervention and complex PCI. So far he has published and co-authored approximately 60 scientific papers in peer-reviewed journals.

His research interests include the transcatheter valve intervention and the optimization of the PCI with imaging & physiology.

Dr. Saibal Kar is an interventional cardiologist of Los Robles Hospital & Medical Center.

Dr. Kar is a skilled interventional cardiologist with a special expertise in valvuloplasty and congenital heart disease. His research interests are focused on coronary restenosis, device development and the advancement of percutaneous techniques in the treatment of congenital and valvular heart diseases.

Involved in both clinical and experimental research, Dr. Kar's clinical work has included publishing data on different aspects of angioplasty for the treatment of acute myocardial infarction. In the experimental lab, he has done original work on newer drugeluting stents for the prevention of restenosis of coronary stents, and he recently developed a new drug-eluting stent, which is being used in a clinical trial in Germany.

Dr Sachin Khambadkone, MD, DNB, MRCP, CCST, is a leading interventional cardiologist who specialises in paediatric and adolescent cardiology among other areas of expertise such as Fontan circulation and interventional catheterisation. He currently works at the well-known Great Ormond Street Hospital (GOSH) as a Consultant in paediatric and adolescent cardiology, and he also practices at BMI The Kings Oak Hospital. Furthermore, he is recognised for his extensive research on transcatheter pulmonary valve implantation.

Dr Khambadkone began his studies in India where he received his diploma in child health at the Royal College of Physicians and Surgeons. He then continued his studies in London at the Royal College of Physicians where he gained his MRCP Paediatrics and CCST Paediatric Cardiology qualifications.

Dr Gi-Beom Kim is an associate professor of the department of pediatrics at Seoul National University Children's Hospital. He received the M.D. and Ph.D. at Seoul National University. His main interests are catheter intervention for diverse congenital heart diseases, cardiomyopathy and Kawasaki disease.

Specialty:
Heart disease, General Pediatric Cardiology, Adult congenital heart disease, Cardiomyopathy, Congenital heart disease, Kawasaki, Acquired heart disease, Pulmonary hypertension

Jung-Sun Kim, MD, PhD is Associate Professor of Medicine at Yonsei University Medical School, Director of the Hybrid Cathroom at Severance Cardiovascular Hospital. Massachusetts General Hospital. Dr. Kim has completed his residency in medicine and fellowship in cardiology in Severance Hospital, Yonsei University and also successfully defended his doctorate thesis at the same university. His research interest has been intracoronary imaging, especially optical coherence tomography (OCT).

For 10 years, he has pioneered the application of OCT to assess the coronary stent. He has a variety of experience for peripheral and aorta stent graft as well as coronary intervention. He has started Structural Heart Intervention including PMV, ASD, PFO and PDA since 2012 and expanded to LAA occlusion, paravalvular leakage and coronary fistula closure. He has been published over 40 SCI /SCIE papers as first or corresponding authors.

Dr Sang Yeub Lee obtained his MD (Medicine), Master's Degree (Medicine) and Doctorate from Chung-ang University School of Medicine. He also obtained Fellowship from Chung-ang University Hospital. He is Clinical Associate Professor at Chungbuk National University Hospital

His specialties include: IHD (ischemic heart disease, hypertension, adult congenital heart disease, arrhythmia

Dr. O'Neill, MD, MSCAI, is Director, Centre for Structural Heart Disease of Henry Ford Hospital. As an internationally recognized leader in Interventional Cardiology and Structural Heart Disease, Dr. O'Neill pioneered in research and new techniques to diagnose and treat heart disease.

Dr. O'Neill pioneered the use of angioplasty for treatment of heart attacks, which is now the mainstay therapy throughout the world. He has been working on new catheter-based treatments of structural heart disease, and performed the first transcaval aortic valve replacement (TAVR) through a catheter in the U.S. in 2005. Currently he is organizing new protocols to treat a deadly side-effect of massive heart attacks, known as the National Cardiogenic Shock Initiative (NCSI). This initiative has proven to increase patient survival rates from 50% to 76%.

Consultant, Pediatric Heart Center, Queen Sirikit National Institute of Child Health (QSNICH), Bangkok, THAILAND
Board Committee, Society of Pediatric Cardiology of Thailand (SPCT)
Board Committee, Thai Resuscitation Council (TRC)

Dr Promphan, M.D., FSCAI., has been working as a consultant of Pediatric Cardiology at QSNICH since 2006 mainly focusing on CHD and SHD Catheter Intervention. His clinical research interests are transcatheter therapy in various congenital heart lesions including the new system for percuteneous pulmonary valve implantation (PPVI) and long-term outcome of ASD device closure.

Dr. Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, FSCCT, an Interventional Cardiologist at Vancouver General Hospital (VGH) and St Paul's Hospital, is also a Clinical Associate Professor of Medicine at the University of British Columbia, and Program Director of the Interventional Cardiology Fellowship Program at VGH. She is also the Head of VGH Cardiology Clinical Trials Research and a physician proctor for left atrial appendage (LAA) closure with the Amplatzer Cardiac Plug/Amulet and WATCHMAN devices globally.

Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD) (http://scad.ubc.ca), and is the principal investigator of the Canadian Institutes of Health Research (CIHR) funded multi-center prospective Canadian SCAD Study. Her other research interests include LAA closure, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention.

Prof. Horst Sievert, M.D., FESC, FSCAI, FACC, is the Director of the CardioVascular Center Frankfurt, and the Department of Internal Medicine, Cardiology and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. He is also a Professor of Internal Medicine/Cardiology at the University of Frankfurt and Honorary Professor at Southend University, UK. In addition, he is currently senior consultant at two other hospitals in the Frankfurt area.

Prof. Sievert received his medical degree at the University Frankfurt, Germany. After training in internal medicine, nephrology, intensive care medicine and radiology, he completed a fellowship in cardiology and vascular medicine.

Dr.K.Sivakumar MD, DCH, DNB(Paedistrics), DM, DNB(Cardiology), is a well-practiced consultant Pediatric Cardiologist associated with Madras Medical Mission Hospital, Chennai. He is successful in a number of critical pediatric cardiac cases.

His specialty is Pediatric Cardiology

Dr. Sivalingam, M.MED, FRCSE, FRCS(C.TH),FRCSI, is a Senior Consultant Cardiothoracic Surgeon who practices at Institut Jantung Negara.

He specialises in Complex Paediatric Cardiac Surgery, Paediatric Valve Repair, Adult Congenital Heart Surgery, and Surgery in Low Birth Weight Babies.

Procedures performed by the doctor include: Complex Paediatric Cardiac, Surgery Paediatric Valve Repair, Adult Congenital Heart Surgery, and Surgery in Low Birth Weight Babies.

Dr. Søndergaard is Consultant Cardiologist of Rigshospitalet, Copenhagen and Professor of Cardiology, University of Copenhagen, Denmark. He was trained in cardiology with special interest in congenital and structural heart diseases.

His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. He has performed >1,000 TAVI procedures. PI for the NOTION I and NOTION II trial investigating TAVI vs. SAVR in younger, lower risk patients. He also led the first-in-human transcatheter mitral valve implantation in 2012.

Shih-Hsien Sung, MD, PhD is an Attending Physician at the Division of Cardiology, Taipei Veterans General Hospital. Dr Sung obtained his MD and PhD degrees from National Yang Ming University where he is currently an Assistant Professor. He was Internal Medicine Chief Resident and went on to obtain Cardiology Fellowship at Taipei Veterans General Hospital. He was a Research Fellow at Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan and at Graduate School of Medical Sciences, Chinese University of Hong Kong, Hong Kong. Dr Sung's clinical and research interests are on heart failure, including left and right side heart failure. He is an interventional cardiologist and is also an echocardiographer.

Minoru Tabata, MD, PhD, MPH, is Surgeon(Cardiothoractic) at Tokyo Bay Urayasu-Ichikawa Medical Centre

Background:
Harvard School of Public Health (M.P.H. 2007)
Clinical Instructor, Division of Cardiothoraic Surgery, Columbia University College of Physicians & OLV clinic MICS Fellowship (2008, Oct-Dec)
Attending Surgeon, Sakakibara Heart Institute (2009-2013)
University of Tokyo (Ph.D. 2014)
Department Chair, Tokyo Bay Urayasu Ichikawa Medical Center (2013-present)

Specialties:
Mitral valve repair, minimally invasive cardiac surgery, heart valve surgery, thoracic aortic surgery, transcatheter aortic valve implantation, complex reoperative cardiac surgery, large database research, outcomes research

Dr Kun-Chong Tam is the attending physician of Cardiology in Kiang Wu Hospital and the Director-General of Macau Association of Cardiovascular Interventions.

MBBS, MRCP (UK), M.Med (Int Med), FAMS, FESC, FACC, FAPSIC

Dr Edgar Tay is Cardiologist and Interventional Cardiologist at Asian Heart & Vascular Centre, Singapore. He graduated with Bachelor of Medicine and Surgery from the National University of Singapore and was admitted as Member of the Royal College of Physicians (United Kingdom). He completed Advanced Specialist Training (Cardiology) at the National University Heart Centre Singapore (NUHCS).

Dr Tay was formerly a Senior Consultant and the Director of the Structural Heart Disease Programme at the National University Heart Centre of Singapore. He is also an Assistant Professor at the Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore. During his work in NUHCS, he started the Transcatheter Aortic Valve Implantation (TAVI) programme, Mitraclip Mitral Valve Repair programme, Percutaneous Pulmonary Valve Implantation Programme and the Balloon Pulmonary Angioplasty programme for Chronic Thromboembolic Pulmonary hypertension. He was awarded the National Medical Excellence Team Award in 2011.

He actively teaches and was the Associate Programme Director for the Cardiology Senior Residency Programme in NUHCS, as well as a Member of the Cardiology Resident Advisory Committee. He has also mentored and trained several post-doctoral students and fellows and helped proctor several overseas physicians in their transcatheter heart valve programmes. He was also invited to share cardiac treatment techniques via satellite transmission to international sites in US, Europe and Asia.

Dr Apostolos Tzikas is an interventional cardiologist specialized in structural and congenital heart disease. He works at AHEPA University Hospital of Thessaloniki, Greece. He has a PhD from the Thoraxcenter, Rotterdam (supervised by Patrick W. Serruys) entitled "The role of advanced imaging in TAVI".

Dr Tzikas is an experienced clinical proctor for St Jude Medical in TAVI and LAA closure and he is responsible for the Amplatzer Cardiac Plug Registry, which has collected data on >1000 patient treated with in 22 centers worldwide.

Dr Wang , MD, Ph D, is Attending Physician and Associate Professorof Pediatrics, Dicision of Pediatric Cardiology, Department of Paediatrics of National Cheng Kung University Hospital

Chief of Pediatric Cardiology section
National Taiwan University Hospital
President of Taiwan Society of Pediatric Cardiology
CEO Taiwan Cardiac Children's Foundation

MBBS (S'pore), FACC, FAMS, FSCAI, ABIM (Internal Med, Cardiology & Interventional Cardiology, USA), ABVM (Vascular Medicine & Endovascular, USA)

Yeo Khung Keong is a Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore (NHCS). He leads the MitraClip programme at NHCS, and his subspecialty interests are in interventional cardiology, structural heart disease, vascular medicine and peripheral arterial interventions.

He is a Clinical Associate Professor with Duke-NUS Medical School and is the Scientific Lead for the Clinical Sciences and Database Core at the National Heart Research Institute Singapore. In research work, he is the Principal Investigator of the SingCLOUD and SingHEART studies. Clin Assoc Prof Yeo is also the Deputy Group Chief Medical Informatics Officer (Research) for SingHealth. He previously served as the Programme Director of the SingHealth Cardiology Senior Residency Programme and also as the Academic Vice-Chair (Training and Education) for the SingHealth Duke-NUS Cardiovascular Academic Clinical Programme (April 2016 to March 2021).

Gerald Yong is an interventional cardiologist at Fiona Stanley Hospital and St John of God Murdoch Hospital in Australia. He trained at Royal Perth Hospital, Northwestern University Chicago and Montreal Heart Institute concentrating on coronary and structural interventions. He set up the service to deliver transcatheter aortic valve replacement (TAVI) in Western Australia.

He is the head of the Western Australian High Risk Aortic Stenosis Service / TAVI program, and the Director of Structural Intervention at Fiona Stanley Hospital. He has proctored TAVI nationally and internationally, and has been an invited speaker on this area in multiple international conference.

Dr. Yoo, PhD, MD, is a cardiac radiologist and leads the Division of Cardiac Imaging. He is a Professor of the Departments of Medical Imaging and Paediatrics at the University of Toronto. Dr. Yoo's main clinical and research activities are Magnetic Resonance (MR) and Computerized Tomography (CT) applications in children with cardiovascular disease and fetal echocardiography. He is an early adopter of 3D printing in paediatric cardiology and surgery. This technique allows preoperative assessment and simulation of the surgical procedures in patients with complex congenital heart disease, morphology teaching and hands-on surgical training.

Current Positions
- July 2012-Present: Staff Radiologist, Department of Diagnostic Imaging, SickKids, Toronto, Ontario, Canada
- Feb. 1999-Present: Professor of Radiology and Paediatrics, University of Toronto, Toronto, Ontario, Canada